Company / Operating Cash Flow
InspireMD, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$21.9M
FY2025
5-year range
-$21.9M / -$9.1M
FY2021-FY2025
Trend
-33.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has declined for 4 consecutive years, from -$9M in FY2021 to -$22M in FY2025.
Based on SEC 10-K filings.
-$22M in FY2025.
Declined from -$16M to -$22M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- InspireMD, Inc.'s operating cash flow has declined for 4 consecutive years.
- In FY2025, operating cash flow decreased 33.5% year-over-year.
- Peak operating cash flow was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$21.9M | -33.5% |
| FY2024 | -$16.4M | -5.4% |
| FY2023 | -$15.5M | -17.7% |
| FY2022 | -$13.2M | -45.5% |
| FY2021 | -$9.1M | +7.4% |
| FY2020 | -$9.8M | -29.0% |
| FY2019 | -$7.6M | +6.5% |
| FY2018 | -$8.1M | -8.5% |
| FY2017 | -$7.5M | +35.4% |
| FY2016 | -$11.6M | +40.1% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026